
Sheela Jitendra Huff
Examiner (ID: 13612, Phone: (571)272-0834 , Office: P/1643 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1811, 1643, 1642, RD00, 1806 |
| Total Applications | 2210 |
| Issued Applications | 1470 |
| Pending Applications | 183 |
| Abandoned Applications | 574 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10279993
[patent_doc_number] => 20150164990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'Compositions and Methods for Preventing and/or Treating Sensorineural Hearing Loss'
[patent_app_type] => utility
[patent_app_number] => 14/109763
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11144
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14109763
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/109763 | Compositions and Methods for Preventing and/or Treating Sensorineural Hearing Loss | Dec 16, 2013 | Abandoned |
Array
(
[id] => 9569236
[patent_doc_number] => 20140186949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'ENHANCING A POPULATION OF INSULIN RELEASING CELLS USING GFR Alpha-1 Agonists'
[patent_app_type] => utility
[patent_app_number] => 14/108531
[patent_app_country] => US
[patent_app_date] => 2013-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9308
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14108531
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/108531 | Enhancing a population of insulin releasing cells using GFR α-1 agonists | Dec 16, 2013 | Issued |
Array
(
[id] => 9408408
[patent_doc_number] => 20140099660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'TDP-43-STORING CELL MODEL'
[patent_app_type] => utility
[patent_app_number] => 14/096943
[patent_app_country] => US
[patent_app_date] => 2013-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 14896
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14096943
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/096943 | TDP-43-storing cell model | Dec 3, 2013 | Issued |
Array
(
[id] => 9518236
[patent_doc_number] => 20140154728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'COMPOSITIONS, SYSTEMS AND METHODS BASED ON THE DIFFERENTIATION OF EPICARDIAL CELLS TO TYPICAL AND ATYPICAL FATES'
[patent_app_type] => utility
[patent_app_number] => 14/095993
[patent_app_country] => US
[patent_app_date] => 2013-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8113
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14095993
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/095993 | COMPOSITIONS, SYSTEMS AND METHODS BASED ON THE DIFFERENTIATION OF EPICARDIAL CELLS TO TYPICAL AND ATYPICAL FATES | Dec 2, 2013 | Abandoned |
Array
(
[id] => 9670404
[patent_doc_number] => 20140234266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'Cultured Hematopoietic Stem Cells and Method for Expansion and Analysis Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/090260
[patent_app_country] => US
[patent_app_date] => 2013-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13075
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14090260
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/090260 | Cultured Hematopoietic Stem Cells and Method for Expansion and Analysis Thereof | Nov 25, 2013 | Abandoned |
Array
(
[id] => 11656129
[patent_doc_number] => 09669112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Animal model of neuronal injury'
[patent_app_type] => utility
[patent_app_number] => 14/646429
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9874
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14646429
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/646429 | Animal model of neuronal injury | Nov 19, 2013 | Issued |
Array
(
[id] => 9448983
[patent_doc_number] => 20140120152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'Scaffold Delivery of Immune Suppressors and Transplant Material for Control of Transplant Rejection'
[patent_app_type] => utility
[patent_app_number] => 14/068872
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 7348
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068872
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/068872 | Scaffold Delivery of Immune Suppressors and Transplant Material for Control of Transplant Rejection | Oct 30, 2013 | Abandoned |
Array
(
[id] => 9463384
[patent_doc_number] => 20140127811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'METHODS AND COMPOSITIONS FOR GENE INACTIVATION'
[patent_app_type] => utility
[patent_app_number] => 14/054042
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 20446
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14054042
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/054042 | Methods and compositions for gene inactivation | Oct 14, 2013 | Issued |
Array
(
[id] => 9448955
[patent_doc_number] => 20140120124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'CELL CAPABLE OF EXPRESSING EXOGENOUS GITR LIGAND'
[patent_app_type] => utility
[patent_app_number] => 14/053997
[patent_app_country] => US
[patent_app_date] => 2013-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9695
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053997
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053997 | Cell capable of expressing exogenous GITR ligand | Oct 14, 2013 | Issued |
Array
(
[id] => 11407279
[patent_doc_number] => 09554563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Genetically modified mice and engraftment'
[patent_app_type] => utility
[patent_app_number] => 14/053182
[patent_app_country] => US
[patent_app_date] => 2013-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 66
[patent_no_of_words] => 22294
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14053182
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/053182 | Genetically modified mice and engraftment | Oct 13, 2013 | Issued |
Array
(
[id] => 11107937
[patent_doc_number] => 20160304906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-20
[patent_title] => 'METHOD FOR POSITIONING AND INTEGRATING TRANSGENE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/024405
[patent_app_country] => US
[patent_app_date] => 2013-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12244
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024405
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/024405 | Method for positioning and integrating transgene and use thereof | Sep 27, 2013 | Issued |
Array
(
[id] => 11900591
[patent_doc_number] => 09770011
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Veterinary composition and methods for non-surgical neutering and castration'
[patent_app_type] => utility
[patent_app_number] => 14/431347
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 12589
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431347
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431347 | Veterinary composition and methods for non-surgical neutering and castration | Sep 26, 2013 | Issued |
Array
(
[id] => 9971150
[patent_doc_number] => 09018159
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/012220
[patent_app_country] => US
[patent_app_date] => 2013-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11508
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14012220
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/012220 | Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof | Aug 27, 2013 | Issued |
Array
(
[id] => 9875324
[patent_doc_number] => 08962590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Prostate cancer vaccine'
[patent_app_type] => utility
[patent_app_number] => 13/968854
[patent_app_country] => US
[patent_app_date] => 2013-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 12313
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13968854
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/968854 | Prostate cancer vaccine | Aug 15, 2013 | Issued |
Array
(
[id] => 10365896
[patent_doc_number] => 20150250900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF DISEASE AND INJURY IN THE NERVOUS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/438765
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 28307
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14438765
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/438765 | Regenerating functional neurons for treatment of disease and injury in the nervous system | Jul 18, 2013 | Issued |
| 13/384333 | Mammalian Genes Involved in Infection | Jul 18, 2013 | Abandoned |
Array
(
[id] => 11843441
[patent_doc_number] => 09730981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-15
[patent_title] => 'Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 13/899198
[patent_app_country] => US
[patent_app_date] => 2013-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 42
[patent_no_of_words] => 26628
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899198
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/899198 | Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids | May 20, 2013 | Issued |
Array
(
[id] => 12362451
[patent_doc_number] => 09955675
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Urokinase-type plasminogen activator transgenic mouse
[patent_app_type] => utility
[patent_app_number] => 14/397091
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11834
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14397091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/397091 | Urokinase-type plasminogen activator transgenic mouse | Apr 24, 2013 | Issued |
Array
(
[id] => 9015533
[patent_doc_number] => 20130230497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'Renovation And Repopulation Of Decellularized Tissues And Cadaveric Organs By Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 13/863308
[patent_app_country] => US
[patent_app_date] => 2013-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14645
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13863308
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/863308 | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells | Apr 14, 2013 | Issued |
Array
(
[id] => 10615040
[patent_doc_number] => 09334475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-10
[patent_title] => 'Method for inducing erythropoietin-producing cell'
[patent_app_type] => utility
[patent_app_number] => 14/390853
[patent_app_country] => US
[patent_app_date] => 2013-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9923
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14390853
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/390853 | Method for inducing erythropoietin-producing cell | Apr 3, 2013 | Issued |